Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

Telomir Pharmaceuticals / Equity Bottom-Up

<ul><li>Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases.</li><li> The company released test results that showed the company's primary treatment, Telomir-1, showed the ability to reverse the suppression of a master tumor suppressor gene that is silenced in many aggressive cancers.</li><li>This continues the exciting preclinical data that should lead to clinical trials in the near future.</li></ul>

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company released test results that showed the company's primary treatment, Telomir-1, showed the ability to reverse the suppression of a master tumor suppressor gene that is silenced in many aggressive cancers.This continues the exciting preclinical data that should lead to clinical trials in the near future.

TELO: 전임상 시험에서 종양 억제 능력 입증